NO862999L - Lipidblanding for membranfluidisering. - Google Patents

Lipidblanding for membranfluidisering.

Info

Publication number
NO862999L
NO862999L NO862999A NO862999A NO862999L NO 862999 L NO862999 L NO 862999L NO 862999 A NO862999 A NO 862999A NO 862999 A NO862999 A NO 862999A NO 862999 L NO862999 L NO 862999L
Authority
NO
Norway
Prior art keywords
membrane
preparation according
lipid
weight
glycerides
Prior art date
Application number
NO862999A
Other languages
English (en)
Norwegian (no)
Other versions
NO862999D0 (no
Inventor
Meir Shinitzky
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO862999D0 publication Critical patent/NO862999D0/no
Publication of NO862999L publication Critical patent/NO862999L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO862999A 1985-07-26 1986-07-25 Lipidblanding for membranfluidisering. NO862999L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75927085A 1985-07-26 1985-07-26

Publications (2)

Publication Number Publication Date
NO862999D0 NO862999D0 (no) 1986-07-25
NO862999L true NO862999L (no) 1987-01-27

Family

ID=25055034

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862999A NO862999L (no) 1985-07-26 1986-07-25 Lipidblanding for membranfluidisering.

Country Status (6)

Country Link
EP (1) EP0213724A1 (ja)
JP (1) JPS6284028A (ja)
AU (1) AU594066B2 (ja)
CA (1) CA1296640C (ja)
FI (1) FI863050L (ja)
NO (1) NO862999L (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857514A (en) * 1985-09-17 1989-08-15 Yeda Research And Development Company, Ltd. Virus inactivation
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US5043329A (en) * 1987-02-17 1991-08-27 Board Of Regents, University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5260284A (en) * 1987-02-17 1993-11-09 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
US4950656A (en) * 1987-02-17 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
AU618972B2 (en) * 1987-10-06 1992-01-16 Houston Biotechnology Incorporated Phosphatidyl treatment of viral disease
DE68904874T2 (de) * 1988-10-31 1993-07-15 Sandoz Nutrition Ltd Organische verbindungen.
EP0370457B1 (en) * 1988-11-23 1992-12-16 Abbott Laboratories Lipid emulsion for treating aids
DE69131163T2 (de) * 1990-05-18 1999-12-23 Tokyo Tanabe Co., Ltd. Asthma heilmittel
US5231090A (en) * 1990-07-30 1993-07-27 University Of Miami Treatment for hypercholesterolemia
US5319116A (en) * 1992-02-12 1994-06-07 Gary Viole Lecithin fractions and dilutions, methods for their preparation and pharmacological uses thereof
US7208180B2 (en) 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
FR3021807B1 (fr) 2014-05-27 2017-09-29 Commissariat A L Energie Atomique Et Aux Energies Alternatives Matrice de photodiodes mesa a ftm amelioree
CN106860705A (zh) * 2017-03-27 2017-06-20 成都海青生物科技有限公司 一种治疗痰淤藴热所致小儿智能低下的中药组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556592C2 (de) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittelzubereitungen auf Basis öliger Lösungen von Phospholipiden
JPS55118419A (en) * 1979-03-05 1980-09-11 Toyama Chem Co Ltd Antihemolytic composition consisting of fat emulsion and immunizator and carcinostatic agent containing the same
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
DE3028074C2 (de) * 1980-07-22 1983-12-08 Kurt Kampffmeyer Mühlenvereinigung KG, 2000 Hamburg Verfahren zur Herstellung eines lecithinhaltigen Produktes
DE3042365C2 (de) * 1980-11-10 1987-01-29 Extrakta Strauss GmbH, 2000 Hamburg Flüssige, lecithinhaltige einphasige Mehrstoffsysteme und Verfahren zu ihrer Herstellung
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
ATE33333T1 (de) * 1984-01-11 1988-04-15 Von Mletzko Armin Dr Diaetetikum.
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica

Also Published As

Publication number Publication date
AU594066B2 (en) 1990-03-01
AU6057986A (en) 1987-01-29
EP0213724A1 (en) 1987-03-11
FI863050A0 (fi) 1986-07-25
CA1296640C (en) 1992-03-03
NO862999D0 (no) 1986-07-25
JPS6284028A (ja) 1987-04-17
FI863050A7 (fi) 1987-01-27
FI863050L (fi) 1987-01-27

Similar Documents

Publication Publication Date Title
NO862999L (no) Lipidblanding for membranfluidisering.
EP0074251B1 (en) Novel lipid fraction, its preparation and pharmaceutical compositions containing same
Lindgren et al. Physical and Chemical Composition Studies of the Lipoproteins of Fasting and Heparinized Human Sera
JP2746287B2 (ja) 脂質置換治療法
JP2011026352A (ja) 神経保護作用を有する栄養補助食品
US6410522B1 (en) Anti-depressant, stress suppressor and mood improver
EP1663157A2 (en) Stabilized formulations of phosphatidylserine
Kidd Phosphatidylserine; membrane nutrient for memory. A clinical and mechanistic assessment
WO2017032270A1 (zh) 预防和/或治疗心脑血管疾病的组合物
Lubin et al. Changes in fatty acid metabolism after erythrocyte peroxidation: stimulation of a membrane repair process
Nagy et al. Alterations of the synaptosomal membrane ‘microviscosity’in the brain cortex of rats during aging and centrophenoxine treatment
US9717734B2 (en) Chewable lipid supplements containing caffeine for increasing alertness, focus and energy
EP0338459A2 (en) Composition for promoting hair growth in androgenetic alopecia and method thereof
US10653708B2 (en) Uses of ether phospholipids in treating diseases
AU2014202925B2 (en) Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
Babu et al. Superoxide dismutase activity and blastogenic response of lymphocytes from copper-deficient rats fed diets containing fructose or cornstarch
US20100196457A1 (en) Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence
Dessi et al. Ruthenium red protects against glutamate-induced neuronal death in cerebellar culture
CN101437507A (zh) 睡眠诱导用口服剂、应激性失眠症改善用口服剂
EP0296205A1 (en) Method and composition for hair growth in common pattern baldness
Vargas-Villarreal et al. TRICHOMONAS VAGINALIS: IDENTIFICATION OF A PHOSPHOLIPASE A–DEPENDENT HEMOLYTIC ACTIVITY IN A VESICULAR SUBCELLULAR FRACTION
US11253531B2 (en) Lipid supplements for reducing nerve action potentials
Boyer et al. Human erythrocyte monoester lipase: characterization and radiochemical assay of the cell-bound enzyme in normal subjects
CN103599337B (zh) 大蒜皂苷脂质体及其制备方法
Dimpfel et al. Electrically evoked potentials in the rat hippocampus slice in the presence of aminophylline alone and in combination with quinolones